General Archive
-
News releases
£3m Dementia Consortium launched to boost dementia drug discovery
New Consortium unites charity, academic and private sectors in search for new treatments for dementia by supporting research into novel…
-
News releases
MRC Technology to Oversee Parkinson’s UK Intellectual Property
MRC Technology will provide Parkinson’s UK with support in oversight and management of intellectual property, allowing Parkinson’s UK to maximise…
-
News releases
MRC Technology and Oxford University Collaborate to Develop Novel Pain Therapeutics for Migraine
The collaboration will screen selective and potent potassium channel activators to develop novel therapeutic interventions in migraine. Drawing on MRC…
-
News releases
MRC Technology to join innovation network at Stevenage Bioscience Catalyst
The relocation of the Centre for Therapeutics Discovery. MRC Technology’s drug discovery unit, will start the next step in campus…
-
News releases
MRC Technology and Boston University Collaborate to Develop anti-IL-16 Antibody for Treatment of Inflammatory Conditions
MRC Technology, a technology transfer organisation, announced today it is collaborating with Boston University to develop an anti-IL-16 antibody for…
-
News releases
MRC Technology and Renishaw Diagnostics Collaborate to Identify and Develop Infectious Disease Diagnostics
MRC Technology and Renishaw Diagnostics Collaborate to Identify and Develop Infectious Disease Diagnostics. Initiative combines expertise to accelerate clinical diagnostic…
-
News releases
MRC Technology advises Bergen TO in successful technology transfer programme
MRC Technology has successfully completed a project in collaboration with Bergen Teknologioverføring AS (BTO) where MRC Technology advised BTO on…
-
News releases
MRC Technology and Arthritis Research UK Launch Joint ‘Call for Targets’
The call aims to identify and fund projects focused on validation of potential small molecule or antibody targets in pathways…
-
News releases
MRC Technology and Parkinson’s UK launch joint ‘Call for Targets’ to slow, stop or reverse the progression of Parkinson’s
The call aims to identify and fund either one or two projects focused on potential small molecule or antibody targets.…
-
News releases
MRC Technology highlights presentation of data for antibody candidate lambrolizumab developed using its humanization technology
The humanized antibody is now being developed by MSD, known as Merck in the US and Canada. Lambrolizumab is an…
-
News releases
MRC Technology supports the ENTENTE Professional Exchange Program to strengthen European knowledge transfer
The primary focus of the exchange program is to strengthen knowledge transfer offices in universities, public research organisations, and hospitals,…
-
News releases
MRC Technology and EMBLEM collaborate to streamline drug development
The initiative will focus on identification of novel druggable targets in the field of small molecules and antibodies, and collaborating…